Premium Nahrungsergänzungsmittel | artgerecht

Mast Cell Therapy: Treatments and Mechanisms

Mast cell therapy refers to medical treatments that target mast cells to control allergic and inflammatory conditions such as mastocytosis and MCAS.

Regular tips about health Regular tips about health

Things worth knowing about "Mast Cell Therapy"

Mast cell therapy refers to medical treatments that target mast cells to control allergic and inflammatory conditions such as mastocytosis and MCAS.

What is Mast Cell Therapy?

Mast cell therapy refers to a range of medical treatment strategies that specifically target mast cells -- specialized immune cells found in virtually all body tissues. Mast cells play a central role in allergic responses and inflammatory processes. When mast cells become overactive or dysregulated, they can trigger a variety of conditions, including mastocytosis, mast cell activation syndrome (MCAS), classic allergies, and life-threatening anaphylaxis.

How Do Mast Cells Work?

Mast cells contain internal granules packed with potent chemical mediators. Upon activation, they release substances such as histamine, tryptase, prostaglandins, and leukotrienes. These mediators trigger the hallmark symptoms of allergic reactions, including itching, skin flushing, swelling, breathing difficulties, and in severe cases, anaphylactic shock. In conditions like mastocytosis, an abnormally high number of mast cells or overactive mast cells accumulate in the body, causing chronic symptoms.

When is Mast Cell Therapy Used?

Targeted mast cell therapy is applied in the following conditions:

Mastocytosis: A rare disorder in which mast cells accumulate abnormally in the skin, bone marrow, and internal organs.
Mast Cell Activation Syndrome (MCAS): A condition where mast cells react excessively to triggers, causing symptoms across multiple organ systems.
Allergies and Anaphylaxis: Immune overreactions in which mast cells play a key role.
Chronic Urticaria: Persistent hives driven by uncontrolled mast cell degranulation.
Bronchial Asthma: A chronic airway disease in which mast cells contribute to inflammation and bronchoconstriction.

Treatment Approaches and Mechanisms of Action

Mast Cell Stabilizers

Mast cell stabilizers such as cromoglicate (cromolyn sodium) and nedocromil prevent degranulation -- the release of inflammatory mediators from mast cells. They are commonly used for allergic asthma, allergic rhinitis, and certain gastrointestinal conditions and are generally well tolerated.

Antihistamines

Antihistamines of the first and second generation block histamine receptors (H1 and H2), counteracting the effects of histamine released by mast cells. They are a cornerstone of treatment for allergies, chronic urticaria, and MCAS.

Biologics and Monoclonal Antibodies

Modern biologic therapies intervene precisely in the mast cell activation cascade. Omalizumab, an anti-IgE monoclonal antibody, reduces the sensitization of mast cells by immunoglobulin E (IgE) and is approved for severe allergic asthma and chronic spontaneous urticaria. Additional biologics targeting mast cell-relevant signaling pathways are currently in clinical development.

Tyrosine Kinase Inhibitors

In systemic mastocytosis, tyrosine kinase inhibitors such as imatinib and midostaurin are used. These agents inhibit the KIT enzyme (also known as CD117), which is frequently constitutively activated in mastocytosis due to the D816V mutation, driving uncontrolled mast cell proliferation.

Corticosteroids

Corticosteroids exert broad anti-inflammatory effects and suppress mast cell activity. They are used in acute allergic reactions, severe MCAS, and systemic mastocytosis but are reserved for short-term use when possible due to their well-known side effect profile with long-term administration.

Epinephrine (Adrenaline)

In life-threatening anaphylactic reactions triggered by massive mast cell degranulation, epinephrine (adrenaline) is the first-line emergency treatment. It acts rapidly to constrict blood vessels and dilate the airways and can be life-saving.

Diagnosis and Treatment Planning

Accurate diagnosis is essential before initiating mast cell therapy. Diagnostic tools include blood tests to measure serum tryptase (a marker of mast cell activity), skin tests, biopsies (e.g., bone marrow biopsy in mastocytosis), and molecular genetic analyses to detect mutations such as KIT D816V. Treatment is tailored individually based on the specific diagnosis and disease severity.

Side Effects and Safety

Tolerability varies significantly across different treatment approaches. While mast cell stabilizers and newer antihistamines are generally well tolerated, tyrosine kinase inhibitors and corticosteroids can cause significant side effects with prolonged use, including nausea, immunosuppression, and hormonal changes. All treatments should be supervised by a qualified physician.

References

Valent P. et al. - Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal. International Archives of Allergy and Immunology, 2012.
Akin C. - Mast cell activation syndromes. Journal of Allergy and Clinical Immunology, 2017.
Gotlib J. et al. - Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis. New England Journal of Medicine, 2016.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category